Healthy future: Consumer demand for biologic drugs will stimulate industry revenue growth

Operators in the Brand Name Pharmaceutical Manufacturing industry have grappled in recent years with one of the largest waves of drug patent expirations in history. As this so-called patent cliff occurred, many blockbuster drugs lost patent exclusivity, enabling low-price generic drugs to inundate the market. As a result, many brand name pharmaceutical manufacturers have contended with intensifying competition from generic manufacturers, cutting into revenue growth. Over the five years to 2022, investments in research and development that generate a high return will occur as many pharmaceutical manufacturers strengthen their drug pipeline with orphan drugs, which typically have a smaller disease population and lower requirements for the number of patients tested during clinical trials...purchase to read more.

Industry Statistics & Market Size
Annual Growth 12-17
Forecast Growth 17-22

Industry Threats & Opportunities

  • The government attempted to stimulate generic drug use by setting favorable reimbursement rates for generic drugs
  • The industry has trimmed its product lines and R&D spending
  • While healthcare reform has benefited the industry, not all effects will be positive
  • Industry Report - Industry Investment Chapter

    The Brand Name Pharmaceutical Manufacturing industry is moderately capital intensive. Pharmaceutical manufacturing requires research laboratories and facilities, manufacturing machinery as well as other technology and equipment, which add to capital costs. However, wage costs are also high as this industry requires skilled labor to provide value-added services. For example, pharmaceutical researchers, scientists, technicians and laboratory assistants typically have considerable education and training, thus resulting in a high average wage. In 2017, for every dollar spent on labor, an estimated $0.23 is spent on capital.Over the past five years, capital expenditures have moderately declined and are expected to continue steadily falling over the next five years. As ...purchase to read more.

    Additional Insights for the Brand Name Pharmaceutical Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Brand Name Pharmaceutical Manufacturing Industry are

  • Establishment of brand names
  • Undertaking pharmaceutical and medicine R&D
  • Degree of globalization in the company
  • IBISWorld analysts also discuss how external factors such as Federal funding for Medicare and Medicaid and Median age of population in the Brand Name Pharmaceutical Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Brand Name Pharmaceutical Manufacturing Industry?

    Pharmaceutical manufacturers develop prescription and over-the-counter products that are used to prevent or treat illnesses in humans or animals. Brand name drugs and medication have patent protection. This industry does not include nutritional supplement or cosmetic product manufacturers.

    Industry Products
  • Oncological products
  • Antidiabetes products
  • Mental health products
  • Respiratory agents
  • Pain products
  • Autoimmune
  • Antihypertensives
  • Industry Activities
  • Pharmaceutical research and development
  • Manufacturing active ingredients used in pharmaceuticals
  • Manufacturing chemical pharmaceutical preparations
  • Manufacturing biological pharmaceutical products
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Federal funding for Medicare and Medicaid
  • Median age of population
  • Number of people with private health insurance
  • Regulation for the Brand Name Pharmaceutical Manufacturing industry
  • Research and development expenditure
  • Trade-weighted index

  • Current Performance
  • Drug pipeline
  • Industry structure
  • Regulation and trade
  • Chart: Revenue Growth

  • Industry Outlook
  • Healthcare reform
  • Drug pipeline
  • International trade
  • Table: Brand Name Pharmaceutical Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Brand Name Pharmaceutical Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Drug, Cosmetic & Toiletry Wholesaling
  • Supermarkets & Grocery Stores
  • Pharmacies & Drug Stores
  • Hospitals

  • Key Selling Industries
  • Biotechnology
  • Chemical Product Manufacturing
  • Medical Device Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Navigational Instrument Manufacturing
  • Soap & Cleaning Compound Manufacturing

  • Products & Services
  • Other
  • Oncological products
  • Antidiabetes products
  • Mental health products
  • Respiratory agents
  • Pain products
  • Autoimmune
  • Antihypertensives
  • Chart: Brand Name Pharmaceutical Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Insurance providers
  • Population demographics
  • Marketing

  • Major Markets
  • Exports
  • Chain stores
  • Mail service providers
  • Clinics
  • Independent retailers
  • Nonfederal hospitals
  • Food stores
  • Other
  • Chart: Major Market Segmentation for the Brand Name Pharmaceutical Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Research and development
  • Depreciation and wages
  • Marketing
  • Chart: Cost Structure Benchmarking – Sector vs Brand Name Pharmaceutical Manufacturing

  • Basis of Competition
  • Internal competition
  • External competition

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Brand Name Pharmaceutical Manufacturing Industry

  • Industry Globalization
    Amgen Inc., Johnson & Johnson, Merck and Co. Inc., AbbVie Inc., Pfizer Inc., Sanofi,
  • Table: Amgen Inc. - financial performance
  • Table: Johnson & Johnson - financial performance
  • Table: Merck and Co. Inc. - financial performance
  • Table: AbbVie Inc. - financial performance
  • Table: Pfizer Inc. - financial performance
  • Table: Sanofi - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Brand Name Pharmaceutical Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Brand Name Pharmaceutical Manufacturing Industry
  • Industry Revenue (2008-2022)
  • Industry Gross Product (2008-2022)
  • Establishments (2008-2022)
  • Businesses (2008-2022)
  • Employment (2008-2022)
  • Exports (2008-2022)
  • Imports (2008-2022)
  • Wages (2008-2022)
  • Total health expenditure (2008-2022)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Table: Industry Financial Ratios
  • A drug made from large-molecule living matter, as opposed to small-molecule chemicals.
  • Biosimilar
  • A drug derived from living organisms and marketed after the patent expiration of similar therapies. Also known as flow-on biologics or biogenerics.
  • Blockbuster Drug
  • A drug that generates annual sales of more than $1.0 billion.
  • Orphan Drug
  • A pharmaceutical or medicine designed to treat certain rare diseases.
  • Outsource
  • To procure goods or services under contract with an outside supplier.
  • Over-The-Counter (Otc) Drugs
  • Medicines that may be sold directly to a consumer without a prescription from a healthcare professional.
  • Patent Cliff
  • The period when numerous patents on blockbuster drugs are set to expire.
  • Review
  • The basis of the FDA's decision to approve an application. It is a comprehensive analysis of clinical trial data and other information prepared by FDA drug application reviewers.
  • What Our Customers Say

    Why buy this report?

    IBISWorld’s Brand Name Pharmaceutical Manufacturing Industry Research Report offers insight into the market at the national level. Our analysis highlights macro trends in the overall sector and the micro trends faced by companies that do business in the Brand Name Pharmaceutical Manufacturing industry. Our five-year outlook forecasts explain how the market is set to change and the product segments that will drive growth.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Brand Name Pharmaceutical Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Brand Name Pharmaceutical Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Brand Name Pharmaceutical Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.